Two experimental lots of hepatitis B vaccine were prepared by purification of HBsAg from human plasma, inactivation at 100 degrees C for 2 min and at 37 degrees C for 72 hours with formalin in a concentration of 1:4000. The former lot comprises purified HBsAg (40 mg/ml) adsorbed with 0.32 mg % Al(OH)3, the latter consists of purified HBsAg stabilized with 0.1% human albumin and adsorbed with 1 mg% Al(OH)3. The immune response after vaccination with the first lot was observed in 54.54% of the vaccinees. The second vaccine after 3 administrations of 80 micrograms/ml each produced a very good primary and a very good secondary immune response. Both vaccines are nonreactogenic and well tolerated by the vaccinees.

Download full-text PDF

Source

Publication Analysis

Top Keywords

purified hbsag
8
immune response
8
[clinical immunological
4
immunological studies
4
studies experimental
4
experimental series
4
series vaccines
4
vaccines hepatitis
4
hepatitis experimental
4
experimental lots
4

Similar Publications

Background: Covalently closed circular DNA (cccDNA) is a stable, episomal form of HBV DNA. cccDNA is a true marker for the intrahepatic events in controlled CHB infection. Quantifying cccDNA is critical for monitoring disease progression, and efficacy of anti-viral therapies.

View Article and Find Full Text PDF

Introduction: Patients with chronic HBV infection (CHI) exhibit defective anti-viral immune-response whose underlying causes still remain unclear. Monocytes act as immune sentinels for pathogens and can regulate immunity via interaction with other immune-cells, apart from differentiating into macrophages. Immune-checkpoint molecules (ICMs) expressed by immune-cells, including monocytes are known to negatively regulate immune-responses.

View Article and Find Full Text PDF

Improving Access to Anti-HDV Testing: Development and Validation of an Affordable In-House ELISA Assay.

ACS Omega

April 2024

Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

In certain low-income nations, the hepatitis Delta virus and hepatitis B virus (HBV) pose a serious medical burden, where the prevalence of hepatitis B surface antigen (HBsAg) is greater than 8%. Especially in rural places, irregular diagnostic exams are the main restriction and reason for underestimation. Utilizing serum samples from a Pakistani isolate, an internal ELISA for the quick identification of anti-HDV was created, and the effectiveness of the test was compared to a commercial diagnostic kit.

View Article and Find Full Text PDF
Article Synopsis
  • - The Hepatitis B virus (HBV) vaccine uses purified surface antigens produced through recombinant DNA technology, targeting a specific region on the virus to induce neutralizing antibodies.
  • - A case study highlighted a vaccinated patient infected with an HBV strain (Eg200) that escaped the vaccine, belonging to genotype D and an uncommon sub-genotype D9 found in Egypt.
  • - The analysis revealed double mutations in a crucial part of the virus (T125M and P127T) that still aligns with the detected serotype of the vaccine escape strain, underscoring the need for ongoing surveillance of such strains for improving vaccination strategies.
View Article and Find Full Text PDF

Background: The synchronous expression of antigen and adjuvant proteins in plant hosts presents an intriguing potential for vaccine production and the enhancement of appropriate immune responses. In this study, we examined the expression of bioactive murine interferon-gamma (mIFN-γ) along with HBsAg in tobacco and lettuce leaves aimed to further perform the analysis of immune responses in the mouse model.

Methods: Monocistronic and bicistronic cassettes, carrying genes encoding mIFN-γ and HBsAg in various orders, were constructed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!